En Es
Categories

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmaceutical companies and veterinary clinics, including clinical chemistry and immunoassay analysers, high quality reagents, and quality control material.
Platinum member
Products Covid-19NewsSummary
Close

Covid-19 Randox Laboratories

Clinical Laboratory

SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Qnostics SARS-CoV-2 Typing are reactive and non-reactive controls intended for use with in-vitro assays for the determination of spike antibodies to SARS-CoV-2. These controls can be used on various analyzers, making them useful in determining precision of testing systems and allows for performance monitoring of multiple test systems.
More details

SARS-CoV-2 Pooling Test
Extensive SARS-CoV-2 Pooling

The Extensive SARS-CoV-2 Pooling is a rapid real-time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care on the Vivalytic analyzer. The SARS-CoV-2 pooling test with lollipop swab allows for the screening of up to 15 patient samples and produces results in less than 45 minutes. Ideal for mass testing, the pooling could be done at the level of a ward, medical specialty, social bubble, or group of colleagues. It has potential for use in other settings, such as pre-operative screening, schools and universities, prisons, nursing homes, primary care, and large workplaces.
More details

SARS-CoV-2 Antibody Control
Acusera SARS-CoV-2 Antibody Control

The Acusera SARS-CoV-2 Antibody Control comprises both reactive and non-reactive controls for anti SARS-CoV-2, and will support assay validation and routine performance monitoring of serological assays for COVID-19. Conveniently supplied in a liquid ready-to-use format with a 30-day open vial stability, waste is kept to a minimum. As a true third party control, independent performance assessment is guaranteed.
More details

SARS-CoV-2 Pooling Test
Vivalytic SARS-CoV-2 Pooling Test

The Vivalytic SARS-CoV-2 Pooling (COVID-19) is a rapid real time PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care to enable the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first. Highly sensitive assays allow for laboratories to accurately detect low positive samples, enabling for effective identification of positive COVID-19 cases in a timely manner.
More details

SARS-CoV-2 IgG (RBD & NP) Test
SARS-CoV-2 IgG (RBD & NP) Array

The Randox SARS-CoV-2 IgG (RBD & NP) array utilizes patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). Maximum sensitivity is ensured through detection of antibodies against both proteins making the assay superior compared to other commercially available serology tests where false negative results are common. Measurement of both RBD and NP IgG antibodies also provides an opportunity to discriminate vaccinated versus naturally infected individuals based on leading vaccine candidates.
More details

SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test

The Vivalytic SARS-CoV-2 Rapid 39 Minute Test is a real time CE marked PCR test cartridge, providing clear and concise results in a timely manner, direct at the point of care. This enables the patient to take the recommended safety precautions without delay. The new SARS-CoV-2 pooling test will allow users to test up to 160 samples a day and has sensitivity of 98% and a specificity of 100% – a world’s first! Released in collaboration with Bosch, the Vivalytic SARS-CoV-2 Rapid 39 Minute Test is not only a rapid testing solution for the detection of SARS-CoV-2 (COVID-19) but an accelerated mass testing solution to effectively and efficiently monitor and detect viral infection from the offset with an aim of minimizing the rise in infections globally.
More details

SARS-CoV-2 Controls
Qnostics’ SARS-CoV-2(SCV2) Q Controls

Qnostics’ SARS-CoV-2(SCV2) Q Controls are single use positive controls intended to support the validation, verification and performance monitoring of molecular assays used in the testing of SARS-CoV-2 (COVID-19). Qnostics controls contain the entire SARS-CoV-2 genome meaning they are compatible with the majority of commercial and in-house assays. As whole pathogen controls they target the whole viral genome, including CDC and WHO consensus sequences.
More details

PCR Analyzer
Vivalytic

Vivalytic is the easiest-to-use and most-comprehensive multiplex PCR platform on the market and provides the broadest range of test options ever seen for its size. Using Randox-patented Biochip Array Technology, the device also supports single-plex and low-plex testing, simplifying the processes for otherwise-complex laboratory test procedures.
More details

Cytokine Arrays
Cytokine Arrays

Randox offer testing solutions for a comprehensive range of cytokines, cytokine receptors and growth factors designed to assist with COVID-19 risk stratification, monitoring of treatment efficacy and recovery. Utilizing patented Biochip technology up to 12 cytokines and growth factors may be detected simultaneously from a single patient sample.
More details

SARS-CoV-2 (COVID-19) Test
Vivalytic Viral Respiratory Tract Infection (VRI) Array

The Vivalytic Viral Respiratory Tract Infection Array Detecting SARS-CoV-2 (COVID-19) can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. One of the world’s first multiplex molecular diagnostic tests to meet the COVID-19 testing recommendations of the World Health Organization (WHO) and the Centers for Disease Control (CDC), it provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made.
More details

Coronavirus COVID-19 Array
Coronavirus COVID-19 Array

The Randox COVID-19 Array targets genes for SARS-CoV-2 and for sarbecovirus (SARS, SARS like, SARS-CoV-2) and are in line with WHO and CDC recommendations. These genes represent conserved regions of the genome and have been chosen due to their sensitivity and specificity. Suitable for use with the Evidence Investigator from Randox, the Lo-Plex Molecular Assay for SARS-CoV-2 (COVID-19) detects both SARS-CoV-2 and Sarbecovirus (confirmatory target), to report COVID-19 positive patient samples.
More details

Coronavirus Array
Extended Coronavirus Array

Suitable for use with the Evidence Investigator from Randox, the Extended Coronavirus Array comprises six strains of coronavirus, including SARS-CoV-2. The wider panel delivers a more comprehensive respiratory screen allowing differentiation between COVID-19 and other respiratory viruses with similar symptoms, ultimately enabling better treatment decisions to be made.
More details
Close

News of Randox Laboratories

Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership

28 Oct 2020
Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership
The game-changing partnership between Randox Laboratories (Crumlin, UK) and Bosch Healthcare (Waiblingen, Germany) continues to alter the testing landscape and capabilities of both laboratory and non-laboratory settings for rapidly detecting COVID-19.
Read More

Randox and Bosch Partner to Launch Molecular Diagnostics Platform

01 Mar 2018
Randox and Bosch Partner to Launch Molecular Diagnostics Platform
Global healthcare diagnostics manufacturer Randox Laboratories has partnered with Bosch Healthcare Solutions GmbH to launch Vivalytic, an all-in-one fully automated solution for molecular diagnostics.
Read More
Close

About Randox Laboratories

Number of Employees: 1000+
Year of Establishment: 1982
Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmaceutical companies and veterinary clinics, including clinical chemistry and immunoassay analysers, high quality reagents, and quality control material.
FaceBook Twitter Google+ Linked in
Cardiac Assay

Cardiac Assay

Model: H-FABP
Request Information

Description:

The H-FABP assay is a biomarker of myocardial ischemia, and is detectable as early as within 30 minutes of release after an ischemic episode. The assay can speed up treatment, and the rapid return to baseline within 24 hours offers potential use with patients with suspected reinfarction.


Send A Message To This Supplier

* Required Information
* Email
To
Randox Laboratories (Cardiac Assay)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions